Tomoko Kuroiwa

Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night‐time gastric acid suppression

T. Shimatani, Masakí Inoue, Tomoko Kuroiwa et al. · Alimentary Pharmacology & Therapeutics · 2003 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: A crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19

T SHIMATANI, Masashi Inoue, Tomoko Kuroiwa et al. · Clinical Pharmacology & Therapeutics · 2006 · 46 citations

Medicine, Pharmacology, Pharmacotherapy +16

Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H_<i>2</i>‐receptor antagonist

T. Shimatani, Masakí Inoue, Tomoko Kuroiwa et al. · Alimentary Pharmacology & Therapeutics · 2003 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Acid-suppressive effects of generic omeprazole: Comparison of three brands of generic omeprazole with original omeprazole

T. Shimatani, Masakí Inoue, Tomoko Kuroiwa et al. · Digestive and Liver Disease · 2006 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +6

Lafutidine, a Newly Developed Antiulcer Drug, Elevates Postprandial Intragastric pH and Increases Plasma Calcitonin Gene-Related Peptide and Somatostatin Concentrations in Humans: Comparisons with Famotidine

Tomohiko Shimatani, Masakí Inoue, Tomoko Kuroiwa et al. · Digestive Diseases and Sciences · 2006 · 20 citations

Medicine, Pharmacology, Pharmacotherapy +9